Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
5.82
0.00
3.50
1.41
3.00
10.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5.82
0.00
3.50
1.41
3.00
10.00
0.00
Raw Material Cost
6.99
2.91
3.20
4.58
4.46
5.60
8.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
46.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.74
4.21
0.42
0.74
3.67
4.12
0.00
Selling and Distribution Expenses
61.47
26.94
17.41
13.13
21.58
22.76
19.85
Other Expenses
-2.29
3.02
3.07
2.82
3.07
2.60
4.86
Total Expenditure (Excl Depreciation)
95.27
64.21
51.70
46.67
60.37
58.50
77.09
Operating Profit (PBDIT) excl Other Income
-89.39999999999999
-64.2
-48.2
-45.300000000000004
-57.400000000000006
-48.5
-77.1
Other Income
158.33
5.44
4.03
0.57
0.07
1.30
0.81
Operating Profit (PBDIT)
72.45
-55.86
-40.98
-40.11
-52.84
-41.60
-67.60
Interest
3.74
4.21
0.42
0.74
3.67
4.12
0.00
Exceptional Items
6.14
-0.76
-9.60
5.72
-23.96
-32.92
0.00
Gross Profit (PBDT)
-1.17
-2.91
0.30
-3.16
-1.46
4.40
-8.68
Depreciation
3.56
2.91
3.20
4.58
4.46
5.60
8.68
Profit Before Tax
71.28
-63.73
-54.19
-39.70
-84.94
-84.23
-76.28
Tax
0.10
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
71.18
-63.73
-54.19
-39.70
-84.94
-84.23
-76.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
71.18
-63.73
-54.19
-39.70
-84.94
-84.23
-76.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
71.18
-63.73
-54.19
-39.70
-84.94
-84.23
-76.28
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
159.22
44.03
14.83
26.76
51.38
102.55
178.43
Earnings per share (EPS)
1.01
-1.55
-2.53
-5.53
-21.57
-22.73
-37.87
Diluted Earnings per share
1.01
-1.55
-2.53
-5.53
-21.57
-22.73
-37.87
Operating Profit Margin (Excl OI)
-1536.91%
0.0%
-1377.14%
-3200.64%
-1912.33%
-485.04%
0.0%
Gross Profit Margin
1286.01%
0.0%
-1456.86%
-2483.66%
-2682.4%
-786.33%
0.0%
PAT Margin
1223.08%
0.0%
-1548.23%
-2807.36%
-2831.2%
-842.34%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 211.77% vs -17.53% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -40.13% vs -36.22% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -11.90% vs 950.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Abeona Therapeutics, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
5.82
17.95
-12.13
-67.58%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5.82
17.95
-12.13
-67.58%
Raw Material Cost
6.99
3.05
3.94
129.18%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
46.00
25.86
20.14
77.88%
Power Cost
0
0
0.00
Manufacturing Expenses
3.74
1.02
2.72
266.67%
Selling and Distribution Expenses
61.47
16.59
44.88
270.52%
Other Expenses
-2.29
2.10
-4.39
-209.05%
Total Expenditure (Excl Depreciation)
95.27
67.48
27.79
41.18%
Operating Profit (PBDIT) excl Other Income
-89.45
-49.53
-39.92
-80.60%
Other Income
158.33
2.70
155.63
5,764.07%
Operating Profit (PBDIT)
72.45
-43.78
116.23
265.49%
Interest
3.74
1.02
2.72
266.67%
Exceptional Items
6.14
0.27
5.87
2,174.07%
Gross Profit (PBDT)
-1.17
14.90
-16.07
-107.85%
Depreciation
3.56
3.05
0.51
16.72%
Profit Before Tax
71.28
-47.59
118.87
249.78%
Tax
0.10
0.02
0.08
400.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
71.18
-47.61
118.79
249.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
71.18
-47.61
118.79
249.51%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
71.18
-47.61
118.79
249.51%
Equity Capital
0
0
0.00
Face Value
0.01
0.05
0.00
Reserves
159.22
57.99
101.23
174.56%
Earnings per share (EPS)
1.01
-0.45
1.46
324.44%
Diluted Earnings per share
1.01
-0.45
1.46
324.44%
Operating Profit Margin (Excl OI)
-1,536.91%
-275.91%
0.00
-1,261.00%
Gross Profit Margin
1,286.01%
-248.10%
0.00
1,534.11%
PAT Margin
1,223.08%
-265.21%
0.00
1,488.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 0.58 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 7.12 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 211.77% vs -17.53% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -8.59 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -40.13% vs -36.22% in Dec 2024
Annual - Interest
Interest 0.37 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -11.90% vs 950.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -1,536.91%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






